8189 — Tianjin TEDA Biomedical Engineering Co Balance Sheet

0.000.00%

Last trade - 00:00

Basic MaterialsHighly SpeculativeSmall CapMomentum Trap

Market Cap
HK$924.06m
Enterprise Value
HK$1.07bn
Revenue
CNY385.48m

Annual balance sheet for Tianjin TEDA Biomedical Engineering Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	C2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	HKAS	HKAS	HKAS	HKAS	—
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	35.5	29.8	9.55	5.93	25.4
Net Total Accounts Receivable
Net Total Receivables	59	42.9	45.1	18.2	10.8
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	260	209	193	190	234
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	126	139	132	113	98.4
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	393	348	337	303	333
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	194	192	218	217	279
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Liabilities	250	247	267	253	310
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	143	101	70.1	50	22.1
Total Liabilities & Shareholders' Equity	393	348	337	303	333
Total Common Shares Outstanding